Effect of spironolactone on survival in patients undergoing maintenance hemodialysis.

ABSTRACT:

Background

Previous studies have reported inconsistent results regarding the advantages or disadvantages of spironolactone use in patients undergoing hemodialysis (HD). This study aimed to evaluate survival according to the use of spironolactone in a large sample of patients undergoing maintenance HD.

Methods

This retrospective study used laboratory and clinical data from the national HD Quality Assessment Program and claims data. The participants of the quality assessment program were patients who had been undergoing maintenance HD for ≥ 3 months, patients undergoing HD at least twice a week. Patients with no spironolactone prescription during the assessment periods were designated as the control group. Patients with one or more prescriptions of spironolactone during the as

SUBMITTER: Kang SH 

PROVIDER: S-EPMC10980200 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature